Search research articles
Contact Us
Filters
Showing results (341-350 of 556) with videos related to
Page
of 56
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
August 6, 2008
[Drug-induced liver injury caused by an herbal medicine, bofu-tsu-sho-san]
Hiroyuki Motoyama, Masaru Enomoto, Takahiro Yasuda, et al.
Nutrients
|
January 8, 2023
The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD
Yoshihiro Kamada, Kensuke Munekage, Takashi Nakahara, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
January 24, 2017
Japanese clinical practice guidelines for congenital biliary dilatation
Hiroki Ishibashi, Mitsuo Shimada, Terumi Kamisawa, et al.
Endocrine
|
October 26, 2010
The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions
Yasuhiro Hamada, Sohei Kitazawa, Riko Kitazawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 29, 2026
Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients
Nobuharu Tamaki, Masayuki Kurosaki, Hironori Ochi, et al.
World Journal of Gastroenterology
|
January 19, 2026
Noninvasive strategies for metabolic dysfunction-associated steatotic liver disease assessment and referral in Japan
Yoshihiro Kamada, Yoshio Sumida, Hirokazu Takahashi, et al.
World Journal of Gastroenterology
|
April 5, 2013
Case of autoimmune hepatitis with markedly enlarged hepatoduodenal ligament lymph nodes
Hideki Fujii, Naoki Ohnishi, Kazuho Shimura, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
November 22, 2016
Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of <i>Helicobacter pylori</i>
Shinya Yamada, Takumi Kawakami, Yoshikazu Nakatsugawa, et al.
American Journal of Nephrology
|
August 11, 2011
Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes
Shunsuke Goto, Hideki Fujii, Keiji Kono, et al.
British Journal of Pharmacology
|
January 12, 2016
Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction
Hideki Fujii, Yuriko Yonekura, Yusuke Yamashita, et al.
Page
of 56
Search research articles
Search
Showing results (341-350 of 556) with videos related to
Sort By:
Page
of 56
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
August 6, 2008
[Drug-induced liver injury caused by an herbal medicine, bofu-tsu-sho-san]
Hiroyuki Motoyama, Masaru Enomoto, Takahiro Yasuda, et al.
Nutrients
|
January 8, 2023
The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD
Yoshihiro Kamada, Kensuke Munekage, Takashi Nakahara, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
January 24, 2017
Japanese clinical practice guidelines for congenital biliary dilatation
Hiroki Ishibashi, Mitsuo Shimada, Terumi Kamisawa, et al.
Endocrine
|
October 26, 2010
The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions
Yasuhiro Hamada, Sohei Kitazawa, Riko Kitazawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 29, 2026
Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients
Nobuharu Tamaki, Masayuki Kurosaki, Hironori Ochi, et al.
World Journal of Gastroenterology
|
January 19, 2026
Noninvasive strategies for metabolic dysfunction-associated steatotic liver disease assessment and referral in Japan
Yoshihiro Kamada, Yoshio Sumida, Hirokazu Takahashi, et al.
World Journal of Gastroenterology
|
April 5, 2013
Case of autoimmune hepatitis with markedly enlarged hepatoduodenal ligament lymph nodes
Hideki Fujii, Naoki Ohnishi, Kazuho Shimura, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
November 22, 2016
Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of <i>Helicobacter pylori</i>
Shinya Yamada, Takumi Kawakami, Yoshikazu Nakatsugawa, et al.
American Journal of Nephrology
|
August 11, 2011
Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes
Shunsuke Goto, Hideki Fujii, Keiji Kono, et al.
British Journal of Pharmacology
|
January 12, 2016
Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction
Hideki Fujii, Yuriko Yonekura, Yusuke Yamashita, et al.
Page
of 56